2-Fucosyllactose Market - Forecast(2023 - 2028)

Report Code: FBR 0528 Report Format: PDF + Excel

2-Fucosyllactose Market Overview

The 2-Fucosyllactose market size was estimated at $31.23 million in 2021, growing at a CAGR of 8.02% during the forecast period 2022-2027. Human milk is very important for infants' good nutrition and immune system development. 2'Fucosyllactose is one of the numerous forms of oligosaccharides found in human milk that also contain microbiota. 2'Fucosyllactose is a trisaccharide made up of galactose, glucose, and fucose, which is a form of oligosaccharide. It is the most significant of all the oligosaccharides, and is necessary for the infant's body to receive proper nutrition. Furthermore, 2'Fucosyllactose boosts newborns' general anti-infective capacity. The 2'Fucosyllactose can be taken by people of all ages, however, the percentage consumed varies by age. 2'Fucosyllactose is critical for reducing the risk of infections such as viral, bacterial, and other illnesses. The increasing awareness about the benefits of 2-Fucosyllactose is one of the major factors driving the growth of the market. Growing inclination towards food supplements in daily diet is set to further enhance the overall market development of the 2-Fucosyllactose Market for the period 2022-2027.

Report Coverage

The report: “2-Fucosyllactose Market Forecast (2022-2027)”, by Industry ARC, covers an in-depth analysis of the following segments of the 2-Fucosyllactose Market.
By Form: Powder and Liquid
By Nature: Organic and Conventional
By End-User: Food & Beverage, Infant Formula, Pharmaceutical and Dietary Supplements.
By Distribution Channel: Hypermarkets/Supermarkets, Convenience Store, Speciality Store, Online Retailers, and others.
By Geography: North America (U.S., Canada, Mexico), Europe (Germany, U.K., France, Italy, Spain, Russia, and Rest of Europe), Asia Pacific (China, Japan India, South Korea, Australia, and New Zealand, and Rest of Asia Pacific), South America (Brazil, Argentina, and Rest of South America), and Rest of the World (the Middle East, and Africa)

Key Takeaways

  • North America dominated the 2-Fucosyllactose Market in 2021 owing to rising awareness about a healthy diet for an infant in this region. The 2-Fucosyllactose Market scope for different regions will be provided in the final report.
  • Increasing investment in R&D by key manufacturers is set to aid the market growth of the 2-Fucosyllactose Market report. The high price of 2-Fucosyllactose is poised to create hurdles for the 2-Fucosyllactose Market
  • Detailed analysis of the Strength, Weaknesses, and Opportunities of the prominent players operating in the market will be provided in the 2-Fucosyllactose Market report.

2-Fucosyllactose Market Revenue Share, By Geography, 2021(%)

 

For More Details on This Report - Request for Sample

2-Fucosyllactose Market Segment Analysis – By End-User

Based on end-user, the market for 2-Fucosyllactose is segmented into Food & Beverage, Infant Formula, Pharmaceutical, and Dietary Supplements. Dietary supplements have the largest share in the 2-Fucosyllactose market in 2021 and also it is estimated to register a higher CAGR of 10.07% during the forecast period 2022-2027. 2-Fucosyllactose is widely used in infant nutrition and as a dietary supplement to support the digestive and immune health of the infant. It increases the anti-infecting capacity of infants. The 2'Fucosyllactose is essential in preventing infections such as viral, bacterial, and other diseases. Additionally, the increasing inclination of consumers towards dietary supplements is increasing the 2-Fucosyllactose market.

2-Fucosyllactose Market Segment Analysis – By Distribution Channel

Based on end-user, the market for 2-Fucosyllactose is categorized in Hypermarkets/Supermarkets, Convenience Store, Speciality Store, Online Retailers, and others. Hypermarkets/Supermarkets held the largest share in the 2-Fucosyllactose market in 2021. Supermarkets/Hypermarkets offer better brand visibility, separate baby sections, an easy shopping experience, and the availability of a wide range of products and brands that increase the 2-Fucosyllactose market. However, Online retailer is estimated to register a higher CAGR of 11.0% during the forecast period 2022-2027 owing to Online Retail Stores providing more discounts and wider options to purchase with diverse product portfolio.

2-Fucosyllactose Market Segment Analysis – By Geography

North America dominated the 2-Fucosyllactose market with a major share of 41% in 2021. This is attributed to the increasing awareness about the health benefits of 2-Fucosyllactose in this region as it is considered safe for infant nutrition. Furthermore, the presence of key manufacturers in this region are introducing innovative products contributing to the growth of the market in this region.

However, Asia Pacific is estimated to grow at a higher CAGR during the forecast period 2022-2027 owing to rising health concerns about gut diseases and other diseases in this region. Increasing the spending capacity of the people in this region is also increasing the growth of the market in this region.

2-Fucosyllactose Market Drivers

Increasing Research & Development and Introduction of New Products by Key Players

Increasing research & development as well as the launch of a new innovative product by key players across the globe is increasing the growth of the 2-Fucosyllactose Market. For instance, in 2019, BASF launched 2-Fucosyllactose (2’-FL), a human milk oligosaccharide (HMO) for infant nutrition through its human nutrition brand, Newtrition. Additionally, a growing preference towards a healthy diet on daily basis among people is also predicted to increase the growth of the 2-Fucosyllactose market during the forecast period 2022-2027.

Growing Acceptance of Human milk oligosaccharides (HMOs) Owing to Its Health Benefits

Increasing acceptance of Human milk oligosaccharides (HMOs) among consumers owing to its several benefits such as it protects against several viral pathogens are increasing the growth of the 2-Fucosyllactose market. The primary components of human milk are oligosaccharides, which come in a variety of compositions and quantities. Consumption of HMOs helps in the reduction of infant mortality rate. According to, According to the United Nations International Children's Education Fund (UNICEF), the mortality rate for children under the age of five was one in 11 in 1990 and one in 26 in 2018. Moreover, the rising concern about gut diseases is increasing the growth of the 2-Fucosyllactose Market during the forecast period 2022-2027.

2-Fucosyllactose Market Challenges

High Cost of Product and Stringent Rules and regulations

The major factor that is set to impede the growth of the 2-Fucosyllactose market is the high cost of the 2-Fucosyllactose product owing to high production expenses. For instance, manufacturers are generating 2-Fucosyllactose, human milk oligosaccharides(HMO), using advanced technologies such as chemical and enzymatic synthesis. These synthetic and enzymatic procedures require a high amount of capital and energy, which increases the overall cost of the product. Another factor that hampers the growth of the market is strict government rules and regulations to launch a new product along with the complicated process regarding the registration of new products.

Market Landscape

Product launches, mergers and acquisitions, joint ventures, and R&D activities are key strategies adopted by players in the 2-Fucosyllactose Market. In 2021, the 2-Fucosyllactose Market share is consolidated by the top ten players present in the market. In the 2-Fucosyllactose Market, the top 10 companies encompass:

  • Nestle S.A
  • Abbott Laboratories
  • Jennewein Biotechnologie GmbH
  • GNUbiotics Sciences
  • FreislandCampina Ingredients
  • Glycosyn LLC
  • The Honest Co
  • Elicityl SA
  • Dextra Group
  • The Hain Celestial Group Inc.

Development:

In March 2021, BASF’s PREBILAC, the first 2’-Fucosyllactose (2’-FL) ingredient received Australia’s Therapeutic Goods Administration approval. For the next two years, BASF will have exclusive rights to supply 2'-FL, a human milk oligosaccharide (HMO) for use in nutritional supplements in Australia.

Relevant Titles:

Gluten Free Food Market - Forecast(2021 - 2026)
Report Code: FBR 0047

Lactose Free Food Market - Forecast(2021 - 2026)
Report Code: FBR 0040

For more Food and Beverage Market related reports, please click here

1. 2-Fucosyllactose Market - Overview
    1.1 Definitions and Scope
2. 2-Fucosyllactose Market - Executive Summary
    2.1 Market Revenue and Key Trends
    2.2 Key trends by Form
    2.3 Key trends by nature
    2.4 Key trends by Geography
3. 2-Fucosyllactose Market – Comparative Analysis
    3.1 Product Benchmarking – Key Companies
    3.2 Financial Analysis – Key Companies
    3.3 Market Value Split by Key Companies
    3.4 Patent Analysis
    3.5 Pricing Analysis- Average Selling Price
4. 2-Fucosyllactose Market - Startup Companies Scenario Premium
    4.1 Key Startup Company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Venture Capital and Funding Scenario
5. 2-Fucosyllactose Market – Industry Market Entry Scenario Premium Premium
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of Successful Ventures
6. 2-Fucosyllactose Market Forces
    6.1 Market Drivers
    6.2 Market Constraints/Challenges
    6.3 Porters five force model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes
7. 2-Fucosyllactose Market – Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8. 2-Fucosyllactose Market – By Form(Market Size –$Million/$Billion)
    8.1 Powder
    8.2 Liquid
9. 2-Fucosyllactose Market – By Nature (Market Size –$Million/$Billion)
    9.1 Organic
    9.2 Conventional
10. 2-Fucosyllactose Market - By End User(Market Size –$Million/$Billion)
    10.1 Food & Beverage
    10.2 Infant Formula
    10.3 Pharmaceutical
    10.4 Dietary Supplements
11. 2-Fucosyllactose Market - By Distribution Channel(Market Size –$Million/$Billion)
    11.1 Hypermarkets /Supermarkets
    11.2 Convenience Stores
    11.3 Specialty Store
    11.4 Online Retailers
    11.5 Others
12. 2-Fucosyllactose Market - By Geography(Market Size –$Million/$Billion)
    12.1 North America
        12.1.1 U.S.
        12.1.2 Mexico
        12.1.3 Canada
    12.2 Europe
        12.2.1 U.K.
        12.2.2 France
        12.2.3 Germany
        12.2.4 Italy
        12.2.5 Spain
        12.2.6 Russia
        12.2.7 Rest of Europe
    12.3 Asia Pacific
        12.3.1 China
        12.3.2 India
        12.3.3 Japan
        12.3.4 South Korea
        12.3.5 Australia & New Zealand
        12.3.6 Rest of APAC
    12.4 South America
        12.4.1 Brazil
        12.4.2 Argentina
        12.4.3 Others
    12.5 Rest of the World
        12.5.1 Middle East
        12.5.2 Africa
13. 2-Fucosyllactose Market - Entropy
14. 2-Fucosyllactose Market – Industry/Segment Competition Landscape Premium
    14.1 Market Share Analysis
        14.1.1 Global Market Share – Key Companies
        14.1.2 Market Share by Region – Key companies
        14.1.3 Market Share by Countries – Key Companies
        14.1.4 Competition Matrix
        14.1.5 Best Practices for Companies
15. 2-Fucosyllactose Market – Key Company List by Country Premium Premium
16. 2-Fucosyllactose Market Company Analysis (Company Revenue, Product, M&A, Developments)
    16.1 Company 1
    16.2 Company 2
    16.3 Company 3
    16.4 Company 4
    16.5 Company 5
    16.6 Company 6
    16.7 Company 7
    16.8 Company 8
    16.9 Company 9
    16.10 Company 10
"*Financials for private companies would be provided on a best efforts basis”.